A Phase 1 and Biodistribution Study of ABT-806i, An Indium-111 Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806.
Saved in:
| Title: | A Phase 1 and Biodistribution Study of ABT-806i, An Indium-111 Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806. |
|---|---|
| Authors: | Hui K. Gan1,2,3 hui.gan@onjcri.org.au, Burge, Matthew4,5, Solomon, Benjamin3,6, Sze Ting Lee1,2,7, Holen, Kyle D.8, Yumin Zhang9, Ciprotti, Marika1, Lee, F. T.1, Munasinghe, Wijith8, Fischer, JuDee8, Ansell, Peter8, Fox, Gerard8, Hao Xiong8, Reilly, Edward B.8, Humerickhouse, Rod8, Scott, Andrew M.1,2,3,7 |
| Source: | Journal of Nuclear Medicine. 8/1/2021, Vol. 62 Issue 8, p1-30. 30p. |
| Database: | Engineering Source |
Be the first to leave a comment!
